logo

Edwards Lifesciences Corp. (EW)



Trade EW now with
  Date
  Headline
8/16/2019 12:04:03 PM Edwards SAPIEN 3 TAVR Receives FDA Approval For Low-Risk Patients
7/23/2019 4:23:54 PM Edwards Lifesciences Corp. (EW) Has Raised Its 2019 EPS Estimate To 5.20 - 5.40 From 5.10 - 5.35.
7/23/2019 4:17:49 PM Edwards Lifesciences Q2 EPS $1.14 Vs. $1.32 Year Ago
6/3/2019 4:17:39 PM Edwards Lifesciences Recommends Stockholders Reject "Mini-Tender Offer" By TRC Capital
5/7/2019 8:18:44 AM Edwards Lifesciences Announces Results From COMMENCE Clinical Study
4/23/2019 4:16:59 PM Edwards Lifesciences Q1 EPS $1.18; Adjusted EPS $1.32
4/18/2019 4:24:09 PM Edwards Lifesciences Completes Acquisition Of CASMED
3/11/2019 8:31:45 AM Edwards Lifesciences Announces Two Strategic Transactions Involving Companies With Structural Heart Disease Technologies
2/12/2019 8:46:19 AM Edwards To Buy CASMED In Cash Deal For $2.45/shr, Or Equity Value Of $100 Mln
2/6/2019 6:31:20 AM Boston Scientific Q4 GAAP EPS $0.27; Adj EPS $0.39